NR4A1 and neoplasm: In our setting, the well-established prognostic biomarkers/factors include age, hormone receptor status, human epidermal growth factor receptor 2 (HER2), tumor size, number of affected nodes, disease grade, tumor proliferation rate, clinical stage, and lymphovascular involvement [3].